| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |